Vol 13, Issue 5, 916-924, May 2003
METHODS
DASH-2: Flexible, Low-Cost, and High-Throughput SNP Genotyping by Dynamic Allele-Specific Hybridization on Membrane Arrays
Magnus Jobs1,
W. Mathias Howell1,
Linda Strömqvist,
Torsten Mayr and
Anthony J. Brookes2
Center for Genomics and Bioinformatics, Karolinska Institute,
Berzelius väg 35, S-171 77 Stockholm, Sweden
 |
ABSTRACT
|
|---|
Genotyping technologies need to be continually improved in terms of
their flexibility, cost-efficiency, and throughput, to push forward
genome variation analysis. To this end, we have leveraged the inherent
simplicity of dynamic allele-specific hybridization (DASH) and coupled
it to recent innovations of centrifugal arrays and iFRET. We have
thereby created a new genotyping platform we term DASH-2, which we
demonstrate and evaluate in this report. The system is highly flexible
in many ways (any plate format, PCR multiplexing, serial and parallel
array processing, spectral-multiplexing of hybridization probes), thus
supporting a wide range of application scales and objectives. Precision
is demonstrated to be in the range 99.8100%, and assay costs are
0.05 USD or less per genotype assignment. DASH-2 thus provides a
powerful new alternative for genotyping practice, which can be used
without the need for expensive robotics support.
As the Human Genome Project moves forward, of major importance will
be analysis of single nucleotide polymorphism (SNP)
(Brookes 1999 ), the most abundant and simple form of DNA variation.
Meaningful exploration of SNPs in most settings demands large-scale
experimentation, and many groups are working towards adequately powered
genotyping technologies to make this possible. Innovative designs
involving enzymes for allele-specific cleavage, ligation, or
polymerization, in conjunction with advanced implementations, have been
brought forward in often fairly successful attempts to accurately score
genotypes (Tsuchihashi and Dracopoli 2002 ). Highly effective systems
have also been fashioned around the straightforward principle of DNA
hybridization (Lay and Wittwer 1997 ; Wang et al. 1998 ; Howell et al.
1999 ). However, assay costs still remain high (typically at least tens
of cents per assigned genotype), and throughputs limited (creating
millions of genotypes remains daunting for most systems). Arguably, the
highly sophisticated and/or multistep reaction chemistries of many of
these procedures may be imposing fundamental limitations on how cheap,
flexible, or prolific they can be made to be. Because of this, we chose
to explore a genotyping strategy that emphasizes simplicity, namely
Dynamic Allele-Specific Hybridization (DASH).
The core reaction principal of DASH is real-time (dynamic) tracking of
allele-specific differences in the process of DNA denaturation. To
achieve this, an oligonucleotide probe is first hybridized to the
target DNAa necessary component of essentially all genotyping
methods. The target DNA comprises one strand of a PCR product
immobilized onto a solid surface, and a single probe is used that is
complementary to one of the target alleles. Probe hybridization is
performed at low temperature so that it goes to completion regardless
of which target allele(s) are present. After probe annealing, there
follows a standard heating step wherein probe-target denaturation is
followed dynamically. This reveals the precise melting temperature
(Tm) at which the probe most rapidly falls off of
the target. The observed Tms are reproducible, and
they discriminate between probe-matched and probe-mismatched targets by
as much as 415°C across all SNPs yet tested. Homozygous samples
give single Tm outputs, while heterozygotes show two
zones of rapid melting. Thus, from this simple reaction process, one
can unambiguously score known alleles present in the assayed target
DNAs. Previously, this assay concept was shown to be very precise
(>99.9% accurate), and improved design principals were recently
reported that overcome problematic secondary structures that may exist
in some target molecules (Prince et al. 2001 ). Our experience shows
that by instigating a basic pipeline around the published
"first-generation DASH" procedure (Howell et al. 1999 ) (96-well
single-plex sample processing, manual pipetting, intercalating dye
fluorescence signals) it is trivial, with just a few staff to create
several hundred thousand genotypes per year, across many hundred
different SNPs, at a reagent cost of 50 cents per
assigned genotype.
Looking to the future of genome variation analysis, there remains an
unmet need for highly flexible single-user technologies that can
produce millions of genotypes per year at a per assignment cost of a
few cents or less. With this goal in mind, we have combined several
recent technology innovations with the basic DASH concept, to create a
new genotyping platform we refer to as "second generation DASH", or
DASH-2. The system is based upon "macro-arrays" on membranes (Jobs
et al. 2002 ), and it uses "iFRET" (Howell et al. 2002 ) to produce
strong fluorescence signals that may be spectrally multiplexed for
increased throughput. PCRs are optionally multiplexed and small volume,
keeping costs at an absolute minimum, and these reactions may be
accessed from any plate format or density. DASH-2 is therefore
extremely flexible in all respects, very cheap to execute, and suitable
for ultrahigh-throughput application. The various components of DASH-2
have now been thoroughly tested, and the findings of those studies are
reported here.
 |
RESULTS
|
|---|
DASH-2 Concept
Figure 1 presents a
schematic overview of the complete DASH-2 procedure. The architecture
of DASH-2 was designed to (1) exploit the proven benefits of DASH
(simplicity and robustness), (2) allow for maximal flexibility of
experimental scale (number of samples assayed) and heterogeneity
(number of SNPs tested), and (3) provide many options for multiplexing
and small-volume processing (to keep costs low). By coupling DASH-2 to
liquid handling and arraying robotics, ultrahigh-throughput genotyping
may be achieved. When such robotics infrastructure is not available,
the DASH-2 procedure nevertheless still supports medium-high-throughput
studies that may be performed completely manually. As presented below,
the individual components of the method were first evaluated
separately. Once optimized, these steps were used in combination to
execute various real-world trials of DASH-2 to meaningfully evaluate
its functionality. This development work was undertaken exclusively
upon real human SNPs (IDs from the Human Genome Variation Database:
HGVbase (Fredman et al. 2002 ) representing the full spectrum of
possible allelic base alternatives.

View larger version (51K):
[in this window]
[in a new window]
|
Figure 1. DASH-2 schematic. DASH-2 examines products from optionally multiplexed,
small-volume PCRs, performed in any density or format of plate
(A). PCR products are transferred to membranes to create
"macro-arrays" by specific capture of one strand on the membrane
surface. In the absence of robotics, this is conveniently achieved by
centrifugation (B). Using robotics (not illustrated), would
allow staggered subarraying of many different plates onto a single
membrane to achieve ultrahigh-throughput. Alkali rinsing (to remove PCR
reagents and make targets single stranded) and saturation hybridization
with allele-specific probe(s) entails immersion in buffer trays or
enlisting special washing platforms, and more than one target per array
feature may be interrogated in parallel by using differentially labeled
("spectrally multiplexed") probes (C). Alternatively,
probe cocktails could be employed to extract different assay (SNP)
results from different features (not illustrated). Fluorescence signals
are generated by means of iFRET (Howell et al. 2002 ). This entails
using an allele-specific probe that is end-labeled with an
acceptor-fluorophore, plus double-strand specific fluorescence dye to
act as fluorescence donor (D). Dynamic tracking of
probe-target denaturation is achieved by heating the membrane array in
a controlled manner while monitoring fluorescence signal changes via a
CCD camera (D). If using a spectrally multiplexed set of iFRET
probes, the target-specific signals are separately visualized by
imaging the array through appropriate optical filters on a rotating
wheel (D). As Tms specific for different
probe-target combinations are reached, the iFRET signals rapidly
disappear. These transitions are plotted as the negative derivative of
fluorescence versus temperature (E), and thereby the target
DNA alleles are revealed as peaks at high (probe matched) and low
(probe mismatched) temperatures. Heterozygous targets show two peaks of
melting behavior. Serial processing of the membrane is also possible,
and thus additional sets of data may be extracted from array features
by rerunning the DASH-2 procedure from the alkali rinse onwards, using
extra sets of iFRET probes (F). Abbreviations: T14, target
PCR products for different SNPs; P14, probes specific for single
alleles of targets T14; lines marked as 1 and 2, distinct iFRET
emission wavelengths from different fluorophores on probes (red and
blue respectively); green circles indicate SYBR Green I dye molecules
that transfer energy (star shapes) to the probe fluorophores, as per
iFRET chemistry, only when the probe is bound to the target.
|
|
PCR Considerations
The effectiveness of DASH-2 will depend upon how well PCRs can be
set up quickly, in low volume, and multiplexed. We employ pipetting
robotics to prepare PCR plates of dried-down DNA samples in
standardized arrangements, in advance of running DASH assays. Small
volume aliquots of complete PCR-mix are added to these at run time, and
sample rehydration then occurs as PCR begins. Testing this system for
12-µL reactions in 1536-well plates and 24-µL reactions in
384-well plates showed it to perform just as well as when using DNA in
solution. However, smaller volume amplifications suffer from excessive
sample evaporation. Testing alternative plate designs and plastics,
plus various sealing systems, suggested that much of the water loss was
occurring through the vessel walls (data not shown). We empirically
determined that polypropylene 384-well plates (ABgene), and 1536-well
polypropylene plates (Greiner bio-one), closed with "Thermo-Seal"
foils (VWR international), substantially limited this volume reduction,
whether using dry-block or water-based thermocycling devices.
Regarding PCR multiplexing, DASH deliberately employs short PCR
products of about 5070 bp (as part of a secondary structure avoidance
strategy; Prince et al. 2001 ) and these should be easier to multiplex
than fragments of several hundred bp in length. To test routine
multiplex PCR in practice, we tried 49 duplex PCRs, 12 triplex PCRs, 4
tetraplex PCRs, and 1 hexaplex PCR, assembled from among 74, 9, 8, and
6 SNPs, respectively, combining primer sets known to work at equivalent
PCR annealing temperatures. Assay success or failure was determined by
analyzing most of the resulting PCR products by first-generation DASH
(Howell et al. 1999 ). Credible melting curves, suitable for genotype
assignment, were seen for 78/97 (80%) of the duplexes, 31/33 (94%) of
the triplexes, 13/16 (81%) of the tetraplexes, and 6/6 (100%) of the
hexaplexes, indicating that routine PCR multiplexing on these levels is
quite effective.
Array Creation
DASH-2 is based upon macro-arrays of PCR products (one strand,
5'-biotinylated) anchored onto streptavidin-coated membranes. For
highest throughput application, robotic arraying devices may be used to
transfer multiple plates of PCR products onto a single membrane,
arranging the transferred DNA sets in a staggered manner, such as in
3 x 3, 4 x 4, or 5 x 5 high-density grids derived from
384-well formatted starting plates. Standard arraying operations such
as these can be performed by any of a range of robotics platforms, and
we have found the Microgrid II by BioRobotics (www.biorobotic.com)
and the Qbot by Genetix (www.genetix.com) to perform equally well and
highly robustly (data not shown). Alternatively, to create DASH-2
arrays from any starting plate without the use of robotics, one could a
centrifugation approach (Jobs et al. 2002 ). That is, after PCR, a
membrane is clamped above an opened PCR plate and the samples are
centrifuged onto the array surface where they bind. To evaluate the
practicality of this more novel approach to array creation, we
attempted to transfer, by centrifugation, 0.55.0-µL volumes of a
PCR product (5'-biotinylated on one strand), from portions of 384- and
1536-well microtiter plates onto a streptavidin-coated membrane. After
alkali removal of the unbound strand, we assessed the DNA transfer by
hybridization with a fluorescently labeled probe complementary to the
bound strand (Fig. 2). For the 384-well
plate, 5-µL volumes consistently transferred perfectly, creating
evenly filled features. Smaller volumes yielded features that were
progressively weaker in the center, with 0.5-µL volumes forming
incomplete circular arcs. For the 1536-well plate, due to the smaller
cross-sectional area of the wells, features became less than perfect
only at sub-1-µL volumes. Fortunately, these feature-shape
differences are unimportant for DASH-2 analysis, because the sum rather
than the pattern of the measured pixel intensities within each feature
area are interpreted as they change with time. Thus, up to the highest
density and lowest volume PCR reactions typically used by researchers
today, we found the centrifugal membrane array concept to be fully
compatible with the needs of DASH-2, offering high-throughput potential
without the use of robotics for array creation.

View larger version (122K):
[in this window]
[in a new window]
|
Figure 2. The quality of membrane array features created by centrifugation is
shown for different volumes of transfer solution, starting from
384-well plates (top image) and 1536-well plates
(bottom image).
|
|
Executing DASH-2 on Arrays
Having established practicalities for PCR and array creation, we
proceeded towards a full DASH-2 experiment. The signal generation
mechanism was to be iFRET (Howell et al. 2002 ), which has previously
shown to give particularly strong and unambiguous DASH signals. The
iFRET chemistry entails utilizing a DNA-intercalating dye as a
fluorescence resonance energy transfer (FRET) donor, plus a probe-bound
fluorophore as a FRET acceptor. To be able to implement this on a
membrane surface, issues of membrane auto-fluorescence first had to be
addressed. Testing a range of membranes showed that autofluorescence
was commonly high enough to be troublesome, and charged membranes had
the additional complication that they interacted with the SYBR Green I
dye used in iFRET, emitting strong background fluorescence (data not
shown). By trial and error, we established that streptavidin coated
inert polypropylene membranes could provide adequate target DNA binding
and low autofluorescence in the DASH-2 procedure.
To conduct an initial DASH-2 experiment, 192 different genomic DNA
samples (amplified for SNP000008200 [A/T] in single-plex PCRs) were
prepared as eightfold replica arrangements of 2-µL volume in a
1536-well PCR plate. PCR products were centrifugally transferred from
this plate to a binding membrane, and this was alkali rinsed and probed
with a single iFRET probe for one of the target alleles. The membrane
was then subjected to the heating phase of the DASH-2 procedure, and
for each feature the probetarget melting curves were so determined
(Fig. 3). Precisely equivalent denaturation
profiles were seen across all eight replicas for each sample, showing
uniformity of the DASH-2 system. Peak denaturation rates indicated
unambiguous sample-specific melting temperatures
(Tms), correlating to one of three expected genotype
patterns previously seen when scoring this marker upon a
first-generation DASH (Howell et al. 1999 ) system run with iFRET
probes. Comparing the derived genotype calls for these 192 samples with
known data derived by first-generation DASH, restriction digestion of
PCR products (Jeffreys 1979 ), and Pyrosequencing (Nyren et al. 1993 )
studies indicated 100% correct genotype calls.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 3. DASH-2 melting curves are shown for all possible genotypes for marker
SNP000008200[A/T]. Eight replicates of each genotype generated by the
DASH-2 system (right) are compared to results produced by the
first-generation DASH platform (left). The df/dT scale is
arbitrary and platform dependent.
|
|
Multiplexing
Multiplexing is concerned with obtaining more results for little or
no increased cost or effort, and there are several nonmutually
exclusive ways this could be built into DASH-2. This can be viewed as
"multiplexing of multiplexing". PCR multiplexing is one obvious
possibility, as discussed above. Other straightforward options would be
parallel processing of plates when creating arrays, and conducting
parallel buffer treatments of membrane arrays.
Aspects of the array structure and the membrane probing can also be
designed to bring benefits of multiplexing. These would include (1)
"spectral-multiplexing"; mixtures of iFRET probes with distinct
emission spectra could be used in a single probing to extract more than
one result per array feature carrying a multiplexed PCR target, (2)
"intrafeature multiplexing"; complete sets of genotypes could be
extracted from highly multiplexed PCR products by serial probing of
membranes, and (3) "interfeature multiplexing"; multiple different
target loci placed at different feature positions, could be extracted
by hybridizing with a cocktail of many different probes. These various
options were explored.
Binding Capacity and Multiplexed Signal Quality
Should the membrane binding capacity or the signal quality in the
presence of additional targets be nominal, then it would not be
possible to derive reliable results from significantly PCR-multiplexed
targets, either by using spectrally multiplexing probes or by serial
probing. To explore these issues, various amounts of a 5'-biotinylated
oligonucleotide carrying a 6-carboxy-X-rhodamine (ROX) label were
centrifuged as 3-µL aliquots from a 1536-well plate onto a DASH-2
membrane. By simply measuring membrane-bound ROX fluorescence signals
after rinsing the membrane, we found that for even up to 10 pmole
(1020-fold excess over a PCR product), the transferred DNA had not
exceeded the membranes binding capacity. Next, to evaluate the
practical relevance of this large binding capacity, we modeled a
multiplexed target in a DASH-2 experiment by creating array features
from 0.35 pmole (weak PCR equivalent) of synthetic oligonucleotides
representing the two single-allele (homozygous) DNA targets
(SNP000574314[A/C]). At the same time, a titration series of features
equivalent to these two mock genotypes were made, also including in the
transfer 0.352.9 pmole of another target oligonucleotide
(SNP000574319[C/G]), so imposing competition (for binding and
subsequent probe hybridization) equivalent to as much as an 8-plex PCR.
Interrogating the membrane by DASH-2 for SNP000574314 yielded clear
melting curves with no noticeable difference in absolute fluorescence
intensities between any of the features (see Fig.
4A). These results indicate
that the iFRET-based DASH-2 system provides sufficient target DNA
binding capacity, absolute signal strength, and nonconfounding effects
from coimmobilized targets, to support genotyping of at least 8-plex
PCR products.

View larger version (36K):
[in this window]
[in a new window]
|
Figure 4. Experiments into aspects of DASH-2 multiplexing are illustrated.
Different genotypes are distinguished by line style, with equivalent
genotypes per panel using the same line style. For each image the df/dT
scale is in platform-dependent arbitrary units. (A) Robustness
of signal strength and quality when multiplexing the PCR were
demonstrated by modeling the presence of competing target molecules.
The stated ratios indicated the amount of true target versus other DNAs
coimmobilized within an array feature and assayed for the true target
by DASH-2. (B) The viability of spectrally multiplexing iFRET
probes is shown by these example genotypes, produced by DASH-2 analysis
of a duplexed PCR. Targets were SNP000574304 and SNP000003618, and the
matching probes were P1 (carrying Bodipy TMR: 560nm emission) and P2
(carrying ROX: 630nm emission), respectively. The probe combinations
used for DASH-2 analysis are shown in each cell. The same DNA samples
are assayed in the top and bottom cells. The left two cells were imaged
through a 560-nm filter, while the right two cells were imaged through
a 630-nm filter. (C) The potential for serial interrogation of
membranes was established by comparing DASH-2 melting curves from
replica arrayed samples after probing for the number of times indicated
in the corner of each cell. (D) The extent to which probe
cocktails may be used to examine different markers at different feature
positions was explored by assaying arrayed single-plex PCRs for 24 SNPs
(two examples shown, as left and right columns of
cells); probe complexities are as indicated. Most markers suffered only
a minimal loss of data quality regardless of the probe cocktail
complexity (left column example), while three SNPs acquired
extra early-melting fluorescence when interrogated by the 254-probe
mixture (right column example).
|
|
Spectral Multiplexing
To explore the utility of spectrally multiplexed probes, duplex PCRs
were performed for SNPs with high frequency alleles
(SNP000574304[A/G] and SNP000003618[C/G]) upon 16 different genomic
DNAs. Samples were transferred into three replica sections of a
1536-well plate, and a membrane array was created by centrifugation.
The triplicate membrane portions were probed with either an equimolar
mixture of two iFRET probes (one for each amplified marker), or
separately with either one of the two probes. The probes carried
different detection dyes, namely ROX and Bodipy TMR, which differ
considerably in their emission spectra. A dynamic temperature ramp was
applied, and the two marker-specific fluorescence signals were
separately tracked by employing two band-pass optical filters. For
Bodipy TMR fluorescence, the filter had a maximum at 560 nm with a
20-nm bandwith, and for the ROX filter the specifications were 630 and
30 nm. Figure 4B illustrates the data generated by this experiment. The
observed genotype counts for the two markers were very different,
5:9:2 versus 1:8:7 (homozygotes matching the
probe:heterozygotes:homozygotes mismatched to the probe), proving that
each SNPs data was not corrupted by signals from the other assay. This,
plus the near identity of the derived melting curves for the
single-plex probings versus duplex-probings with spectral resolution,
demonstrates that spectral duplexing of iFRET probes works well for
DASH-2 analysis.
Intrafeature Multiplexing
Experiments were performed to establish how many times membranes
could be reprobed to serially extract genotypes from individual
features. Ten replica DASH-2 membranes containing single-plex PCR
products for SNP000015168[A/T] were prepared. One membrane was
processed to extract available genotypes, while nine were held back.
One of the nine membranes plus the already processed membrane were then
processed together through the DASH-2 procedure. By recycling in this
way seven more times, each time adding one more virgin membrane to the
processed set, a series of membranes were generated that had been
serially processed between zero and nine times. Finally, all 10
membranes were processed one last time in parallel. Checks were made
after the alkali rinse (i.e., before probing) to make sure that no
residual probe (fluorescence) was carried through from earlier
hybridizations, and the eventual DASH-2 melting curves were compared
(Fig. 4C). It was apparent that data quality was relatively unchanged
up to five repetitions. Between 510 runs the data quality decreased,
although reliable genotypes could still be extracted from the very last
run of the experiment. Thus, at least five serial hybridizations may be
employed without loss of assay quality, and this could be used to
extract multiple genotypes from individual array features carrying
multiple target DNAs.
Interfeature Multiplexing
For diagnostic applications (testing many known mutations in an
individual), or when examining different SNPs across different
subportions of a PCR plate, it would be useful to be able to use a
cocktail of iFRET probes such that each would automatically hybridize
only to its cognate targets. To assess whether this might work in
practice, a membrane was prepared from a 384-well PCR plate, carrying
16 sample DNAs amplified by single-plex PCRs for 24 different SNPs
(SNP000007612[C/G], SNP000834421[C/T],
SNP000782464[A/G], SNP001265242[G/T], SNP001265241[G/T],
SNP000794409[A/G], SNP000783245[C/G], SNP000782459[C/G],
SNP000782466[G/T], SNP001251211[A/C], SNP000080953[A/G],
SNP001259858[A/T], SNP001257116[A/G], SNP000763322[A/G],
SNP001257107[C/G], SNP000990182[A/G], SNP000108876[A/G],
SNP000108526[A/G], SNP000108654[G/T], SNP000108052[A/G],
SNP001159272[A/T], SNP000707079[A/G], SNP001164148[A/C],
SNP000120603[A/G]). Cocktail probing was then attempted.
First, the membrane was interrogated via DASH-2 with a probe mixture
containing probes for 23 of the 24 assays (one probe omitted as a
negative control). Second, the membrane was treated with alkali, and
reprobed with a combination of the 23 SNP specific probes plus 231
unrelated probes (for other DASH-2 assays not present on the
membrane). All probe mixtures contained 0.33 pmole/µL of each probe.
To provide reference controls, the DNA samples were also scored for
each of these individual SNPs by single-plex first-generation DASH
using iFRET signal generation. The melting curves obtained for the 23
and 254 probe cocktails were very similar to results produced when
assaying the SNPs individually (Fig. 4D), and the negative controls
were negative. Specifically, for the 23-plex cocktail, the melting
curves were essentially identical to the singly probed assays for all
tested SNPs. For the 254-plex cocktail, the melting curves were highly
similar to the single probings for 20 of the SNPs, while three assays
had an additional fluorescence component that disappeared (denatured)
at very low temperature. High-complexity probe cocktails can therefore
occasionally generate some crosshybridization between noncognate
probe-target pairs, but these duplexes denature early in the DASH-2
temperature gradient. Consequently, the additional signals do not
excessively interfere with the melting profiles observed at the higher
temperatures where true marker alleles are normally distinguished.
Probe cocktails thus work well in DASH-2 analysis, and while the upper
complexity limit is yet to be demonstrated, extrapolation from present
results suggests that several thousand probes might be able to function
together.
Trial Applications
To tie together all the above developments, and evaluate them for
cost and precision in a real application, we used DASH-2 to analyze
1494 samples. Among these, 44 DNA samples were duplicated on different
plates as an internal control for genotype calling accuracy, and 42
water controls were also included. The samples were scored for six
SNPs (SNP000574304[A/G], SNP000003618[C/G],
SNP000007612[C/G], SNP000015168[A/T], SNP000063124[C/T], and
SNP000003288[C/T]). The experiment employed three-plex PCRs
of 2-µL volume, performed in 384-well plates. Two sets of four
derived membranes (each set carrying the different three-plex PCR
products) were serially probed three times with single iFRET probes for
their component SNPs. This compact study of only eight 384-well plates
was thus structured to yield 9216 different genotypes (less duplicates
and controls).
Results from this experiment were uniform across all plates and assays,
and negative controls were all negative. A total of 45 samples
repeatedly failed to provide any, or anything but weak, melting curve
signals, and hence, this was assumed to be due to low concentration or
degraded DNA stocks that were difficult to PCR amplify. Other than
these, 25 singleton failures were observed, giving a sample dropout
rate of <0.3%. Genotyping precision was estimated in three ways.
First, Hardy Weinberg Equilibrium was assessed for each marker, and no
significant deviations were observed. Second, we compared a number of
derived genotypes (329 DNAs typed for two SNPs) to separately
determined and triply-confirmed assignments obtained by other methods
(first-generation DASH, restriction digestion of PCR products; Jeffreys
1979 ; and Pyrosequencing; Nyren et al. 1993 ). Among these 658
genotypes, >99.8% identical calls were made by the DASH-2 system
(difference due to a single genotype discrepancy). Third, we examined
the results obtained for the 528 internal replicates built into the
experiment (264 duplicates, comprising 44 samples scored for six SNPs).
For these we found that the calls agreed in 100% of the cases. Thus,
the accuracy of the DASH-2 system is in the range 99.8100%, matching
the precision established previously for the first-generation DASH
system (Prince et al. 2001 ).
 |
DISCUSSION
|
|---|
Basic DASH chemistry, executed under standard reaction conditions
with optimal assay design rules implemented by "DFold" software (D.
Fredman, M. Jobs, and A.J. Brookes, in prep.), has
previously been shown to be highly robust and able to genotype well in
excess of 95% of all real SNP sequences with a precision of over
99.9%. By building new innovations into this DASH chemistry, and
transferring the procedure to an array implementation, we have now
created the powerful and highly flexible "DASH-2" system.
DASH-2 is based upon the use of macro-arrays of target DNAs. This
offers a range of advantages, not least (1) target DNA processing and
probing is reduced to direct immersion of membranes in suitable buffer
solutions, (2) multiple membranes may be parallel-processed during
their creation and interrogation, (3) membranes containing multiplexed
PCR products may be serially interrogated many times to extract all
available genotypes, (4) monitoring of the dynamic assay step
(probe-target denaturation) entails simple real-time CCD imaging of the
full array, and (5) array features of any scale or density can be
processed equivalently. Creating these arrays is made simple by the use
of low-cost centrifugation procedures. Alternatively, if one wished to
employ robotic arraying devices, throughput could be increased further
by condensing PCR products from multiple plates onto individual
membranes in a staggered arrangement, thereby significantly reducing
downstream membrane processing effort.
For a signal generation system, DASH-2 takes advantage of the proven
benefits of iFRET. Previous work demonstrated that iFRET eliminates
background signals due to target DNA secondary structures. We have now
shown that iFRET is effective as a way to achieve spectral multiplexing
in DASH-2 analysis. Our data specifically demonstrate spectral
duplexing, but given available dyes and the generality of iFRET, it is
likely that up to fourfold spectral multiplexing may be possible,
particularly if applying mathematical deconvolution of signals.
Fundamentally, the power of DASH-2 emerges from its many and varied
uses of multiplexinga principle that is endorsed by other notable
methods such as the MASDA assay (Shuber et al. 1997 ). DASH-2
multiplexing options include, (1) PCR multiplexing, (2) parallel
processing of array preparation and buffer treatments, (3) use of
spectrally multiplexed sets of iFRET probes to extract several marker
results from each array feature, (4) use of probe cocktails to derive
results from features carrying different target loci, and (5) repeated
probing to serially extract data from features derived from highly
multiplexed PCRs. This "multiplexing of multiplexing" underpins the
methods flexibility, enables high-throughput application, and helps to
keep genotyping costs very low. The fact that the method only requires
a single end-labeled fluorescent iFRET probe also ensures cost
efficiency. By way of example, in the final experiment we report, the
plastic-ware plus enzyme plus reagent cost for the full set of 9216
genotypes was only 460 USD. That equates to only 0.05 USD per genotype.
Minimal further multiplexing, PCR volume reduction, and the use of
1536-well plates (or roboticized subgridding) would easily bring this
cost down several fold to 0.010.02 USD per genotypeat least an
order of magnitude cheaper than most other fully reported systems.
To help the research community avail itself of DASH genotyping,
suggested assay designs (PCR primer and hybridization probe sequences)
are being assembled, via "DFold" software (D. Fredman, M. Jobs, and
A.J. Brookes, in prep.), for all known human SNPs
represented in the public HGVbase human polymorphism database (Fredman
et al. 2002 ). These designs will be presented as part of the records in
that database. An experimentally validated list of proven cSNPs
(variants that alter amino acid sequences) plus DASH assay reagents is
also being constructed, built upon all available entries in that
database. In terms of practical assistance, novel SNP assay design help
and quality-controlled validated kits of DASH reagents may be obtained
from a dedicated DASH-support company (DynaMetrix,
www.dynametrix-ltd.com). These components may be used with
first-generation DASH (Howell et al. 1999 ) protocols for
low-medium-throughput studies (several thousand genotypes per week per
assay device) or with the multiplexed DASH-2 protocols presented here
for high-throughput applications (one million or more genotypes per
week per assay device).
In conclusion, DASH-2 provides a powerful new alternative for
genotyping practice. It is flexible and cheap enough for all to use,
and it does not require expensive robotics or assay devices to be
purchased. These benefits stem directly from the elemental simplicity
of the underlying DASH reaction concept, which perhaps also has
potential for expression array analyses, (re)sequencing, and DNA
fingerprinting. We additionally envisage further implementation
improvements towards DASH-3 (e.g., nano-scale and microbead versions)
that could bring even faster and cheaper genotyping possibilities in
the relatively near future.
 |
METHODS
|
|---|
PCR
Polymerase Chain Reacion (PCR) primers for DASH-2 assays were
designed using the DFold software (DynaMetrix Ltd, UK: D. Fredman, M.
Jobs, and A.J. Brookes, in prep.). All PCR reaction mixes
were scaled from the following basic protocol. A 1-µL reaction
contained 0.15 pmole 5'-biotinylated primer, 0.75 pmole of nonlabeled
primer, 0.03 units AmpliTaq Gold® DNA polymerase (PE Corp.), 1x
AmpliTaq Gold® Buffer, 3 mM MgCl2, 5% Dimethylsulphoxide,
and 0.2 mM of each dNTP. Genomic DNA ranged from 1 ng down to 0.25 ng
per reaction and never less, thereby negating any risk of stochastic
preferential amplification of one allele due to low target copy number.
Thermal-cycling consisted of an initial 10-min activation step of
94°C for 10 min, followed by 40 cycles of 94°C for 15 sec and an
assay-specific annealing temperature for 30 sec. PCRs were performed in
15-µL volumes in 384-well polypropylene plates (ABgene) or
12-µL volumes in the 1536-well polypropylene plates (Greiner
bio-one). The 384-well plates were heat-sealed using the Easy-Peel heat
sealing foil (ABgene) and the 1536-well plates were sealed with
Thermo-seal heat sealing foil (VWR international). Thermal cycling was
performed on a 384 MultiBlock System (Thermo-Hybaid) or in a water
bath-based thermal cycling unit developed in-house. For multiplex PCR,
primer combinations were done such as to maintain the same reagent
concentrations as for regular PCR, and thermal cycling was performed as
described above.
Transfer and Binding to Membrane
Sample transfer from a microtiter plate to a membrane was
accomplished via centrifugation as previously described (Jobs et al.
2002 ). In brief, a streptavidin-coated polypropylene membrane
(DynaMetrix Ltd, UK) was prewet in HEN buffer (0.1 M HEPES, 10 mM EDTA,
50 mM NaCl, pH 7.5) and placed on top of the open wells of a microtiter
plate (384 wells or 1536 wells). A compression pad (HB-TD-SFOAM,
Hybaid) was then placed on top of the membrane, and the arrangement was
pressed together in a clamping device. The device was then placed in a
microtiter plate centrifuge (B4i Jouan, Inc) and centrifuged at 1500
rpm (rotor s20) for 30 sec. The device was left at room temperature for
30 min (to allow the biotinylated PCR products to bind to the
strepatividin-coated membrane). Finally, the clamping device was
inverted and briefly centrifuged to return the remaining fluid back
into the microtiter plate wells.
Probe Hybridization
Membranes were submerged in a 0.1 M NaOH bath for 2 min to remove
nonbiotinylated PCR product strands. They were then rinsed once in HEN
for neutralization, and placed separately on 8 x 12-cm glass plates
(slightly larger than the membrane). A 1.5-mL HEN solution containing
0.5 pmole/µL of the appropriate oligonucleotide probe was added onto
each membrane, and a second glass plate was placed on top to form a
hybridization chamber. The individually sandwiched membranes were
heated to 85°C on a flat PCR block (PCR express, Thermo Hybaid) and
air cooled to room temperature. A final rinsing in HEN was then applied
to remove excess probe.
DASH-2 Analysis
Membranes, carrying the bound probe-target duplexes, were soaked
for 30 min in 0.5x HE buffer (0.1 M HEPES, 10 mM EDTA, pH 8.0)
containing a 1:10,000 dilution of supplied stock SYBR Green I dye
(Molecular Probes). They were then individually sandwiched between two
glass plates and placed into a DASH-2 genotyping device (DynaMetrix
Ltd). The device consisted of a dark box, a heating platform, a light
source, and a CCD camera with appropriate optical filters. Fluorescence
values were collected as the membrane assembly was heated from
3585°C (with a heating rate of 23°C/min) by imaging every
0.5°C.
Genotype Calling
Melting curves were generated for each array feature by purpose
built software (DynaMetrix Ltd). Denaturation events were most readily
visualized by analysis of a plot of the negative derivative of the
fluorescence versus temperature profile. Presence of a single
high-temperature peak indicated the sample was homozygous for the
allele complementary to the allele present in the oligonucleotide
probe. A single low-temperature peak indicated homozygosity for the
alternative allele. A curve with peaks at both temperatures indicated
that the sample was heterozygous.
 |
WEB SITE REFERENCES
|
|---|
www.biorobotic.com; suppliers of lab-robotic equipment.
www.genetix.com; suppliers of lab-robotic equipment.
www.dynametrix-ltd.com; supplies and supports SNP genotyping by Dynamic
Allele-Specific HybridizationDASH.
 |
Acknowledgements
|
|---|
We gratefully acknowledge the Swedish Research Council & Carl
Tryggers Foundation for Scientific Research for funding that helped
with aspects of our research undertakings, and we thank the Karolinska
Institute Center for Genomics and Bioinformatics and Pharmacia
Corporation for provision of enabling infrastructure. General technical
assistance by various members of our laboratory is appreciated, and in
particular, we thank David Fredman, Daniel Pederson, Johan Klingberg,
and Mark Reimers for innovative software contributions.
The publication costs of this article were defrayed in part by payment
of page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 USC section 1734 solely to
indicate this fact.
 |
Footnotes
|
|---|
1 These authors contributed equally. 
2 Corresponding author. 
E-MAIL Anthony.Brookes{at}cgb.ki.se; FAX 46 8 324826.
Article and publication are at
http://www.genome.org/cgi/doi/10.1101/gr.801103.
 |
REFERENCES
|
|---|
Brookes, A.J. 1999. The essence of SNPs. Gene 234: 177-186.[CrossRef][Medline]
Fredman, D., Siegfried, M., Yuan, Y.P., Bork, P., Lehvaslaiho, H., and Brookes, A.J. 2002. HGVbase: A human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res. 30: 387-391.[Abstract/Free Full Text]
Howell, W.M., Jobs, M., and Brookes, A.J. 2002. iFRET: An improved fluorescence system for DNA-melting analysis. Genome Res. 12: 1401-1407.[Abstract/Free Full Text]
Howell, W.M., Jobs, M., Gyllensten, U., and Brookes, A.J. 1999. Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms. Nat. Biotechnol. 17: 87-88.[CrossRef][Medline]
Jeffreys, A.J. 1979. DNA sequence variants in the G -, A -, - and -globin genes of man. Cell 18: 1-10.[CrossRef][Medline]
Jobs, M., Howell, W.M., and Brookes, A.J. 2002. Creating arrays by centrifugation. Biotechniques 32: 1322-1324., 1326, 1329.[Medline]
Lay, M.J. and Wittwer, C.T. 1997. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin. Chem. 43: 2262-2267.[Abstract/Free Full Text]
Nyren, P., Pettersson, B., and Uhlen, M. 1993. Solid phase DNA minisequencing by an enzymatic luminometric inorganic pyrophosphate detection assay. Anal. Biochem. 208: 171-175.[CrossRef][Medline]
Prince, J.A., Feuk, L., Howell, W.M., Jobs, M., Emahazion, T., Blennow, K., and Brookes, A.J. 2001. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): Design criteria and assay validation. Genome Res. 11: 152-162.[Abstract/Free Full Text]
Shuber, A.P., Michalowsky, L.A., Nass, G.S., Skoletsky, J., Hire, L.M., Kotsopoulos, S.K., Phipps, M.F., Barberio, D.M., and Klinger, K.W. 1997. High-throughput parallel analysis of hundreds of patient samples for more than 100 mutations in multiple disease genes. Hum. Mol. Genet. 6: 337-347.[Abstract/Free Full Text]
Tsuchihashi, Z. and Dracopoli, N.C. 2002. Progress in high-throughput SNP genotyping methods. Pharmacogenomics J. 2: 103-110.[CrossRef][Medline]
Wang, D.G., Fan, J.B., Siao, C.J., Berno, A., Young, P., Sapolsky, R., Ghandour, G., Perkins, N., Winchester, E., Spencer, J., et al. 1998. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280: 1077-1082.[Abstract/Free Full Text]
Received January 29, 2003;
accepted in revised format February 26, 2003.
13:916-924 © by 2003 Cold Spring Harbor Laboratory Press ISSN 1088-9051/03 $5.00

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Petersen, L. Poulsen, S. Petronis, H. Birgens, and M. Dufva
Use of a multi-thermal washer for DNA microarrays simplifies probe design and gives robust genotyping assays
Nucleic Acids Res.,
February 2, 2008;
36(2):
e10 - e10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Schwartzbaum, A. Ahlbom, S. Lonn, B. Malmer, A. Wigertz, A. Auvinen, A. J. Brookes, H. Collatz Christensen, R. Henriksson, C. Johansen, et al.
An International Case-Control Study of Interleukin-4R{alpha}, Interleukin-13, and Cyclooxygenase-2 Polymorphisms and Glioblastoma Risk
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2007;
16(11):
2448 - 2454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Schwartzbaum, A. Ahlbom, S. Lonn, M. Warholm, A. Rannug, A. Auvinen, H. C. Christensen, R. Henriksson, C. Johansen, C. Lindholm, et al.
An International Case-Control Study of Glutathione Transferase and Functionally Related Polymorphisms and Risk of Primary Adult Brain Tumors
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2007;
16(3):
559 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Stromqvist Meuzelaar, K. Hopkins, E. Liebana, and A. J. Brookes
DNA Diagnostics by Surface-Bound Melt-Curve Reactions
J. Mol. Diagn.,
February 1, 2007;
9(1):
30 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schwartzbaum, A. Ahlbom, B. Malmer, S. Lonn, A. J. Brookes, H. Doss, W. Debinski, R. Henriksson, and M. Feychting
Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme
Cancer Res.,
July 15, 2005;
65(14):
6459 - 6465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mund, V. Beier, P. Bewerunge, M. Dahms, F. Lyko, and J. D. Hoheisel
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines
Nucleic Acids Res.,
April 28, 2005;
33(8):
e73 - e73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Jannink
Selective Phenotyping to Accurately Map Quantitative Trait Loci
Crop Sci.,
March 28, 2005;
45(3):
901 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wiklund, B.-A. Jonsson, A. J. Brookes, L. Stromqvist, J. Adolfsson, M. Emanuelsson, H.-O. Adami, K. Augustsson-Balter, and H. Gronberg
Genetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer
Clin. Cancer Res.,
November 1, 2004;
10(21):
7150 - 7156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wakai, A. Takagi, M. Nakayama, T. Miya, T. Miyahara, T. Iwanaga, S. Takenaka, Y. Ikeda, and M. Amano
A novel method of identifying genetic mutations using an electrochemical DNA array
Nucleic Acids Res.,
October 21, 2004;
32(18):
e141 - e141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Gu, S. Efendic, S. Nordman, C.-G. Ostenson, K. Brismar, A. J. Brookes, and J. A. Prince
Quantitative Trait Loci Near the Insulin-Degrading Enzyme (IDE) Gene Contribute to Variation in Plasma Insulin Levels
Diabetes,
August 1, 2004;
53(8):
2137 - 2142.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|